Jennifer Sue Pitrak Mcdonald

Array ( [id] => 4652158 [patent_doc_number] => 20080039414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/693059 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 86506 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039414.pdf [firstpage_image] =>[orig_patent_app_number] => 10693059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738988 [patent_doc_number] => 20060009379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Methods for controlling proliferation of cells' [patent_app_type] => utility [patent_app_number] => 10/530340 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25397 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009379.pdf [firstpage_image] =>[orig_patent_app_number] => 10530340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5011417 [patent_doc_number] => 20070281896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Novel compositions and methods in cancer' [patent_app_type] => utility [patent_app_number] => 10/676684 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 50914 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281896.pdf [firstpage_image] =>[orig_patent_app_number] => 10676684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23197 [patent_doc_number] => 07794930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Snail, a new marker for tumour invasion and target protein of new antitumoral compounds' [patent_app_type] => utility [patent_app_number] => 10/461256 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 5117 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794930.pdf [firstpage_image] =>[orig_patent_app_number] => 10461256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727465 [patent_doc_number] => 20060058225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease' [patent_app_type] => utility [patent_app_number] => 10/516241 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19742 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058225.pdf [firstpage_image] =>[orig_patent_app_number] => 10516241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7373170 [patent_doc_number] => 20040006780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'VEGF-modulated genes and methods employing them' [patent_app_type] => new [patent_app_number] => 10/428487 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 46647 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006780.pdf [firstpage_image] =>[orig_patent_app_number] => 10428487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190270 [patent_doc_number] => 20040204374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Cis-element decoys useful as anti-tumor therapeutics' [patent_app_type] => new [patent_app_number] => 10/411692 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4157 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204374.pdf [firstpage_image] =>[orig_patent_app_number] => 10411692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846992 [patent_doc_number] => 20030166159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Novel transcription factor regulating TNF-alpha' [patent_app_type] => new [patent_app_number] => 10/405738 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10041 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166159.pdf [firstpage_image] =>[orig_patent_app_number] => 10405738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797099 [patent_doc_number] => 20030175973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Targeted recombinant viral vectors' [patent_app_type] => new [patent_app_number] => 10/393694 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7271 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175973.pdf [firstpage_image] =>[orig_patent_app_number] => 10393694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865111 [patent_doc_number] => 20030190637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Mutations in spink5 responsible for netherton\'s syndrome and atopic diseases' [patent_app_type] => new [patent_app_number] => 10/220510 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16654 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190637.pdf [firstpage_image] =>[orig_patent_app_number] => 10220510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252102 [patent_doc_number] => 20050142535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Ogligonucleotides comprising alternating segments and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/503120 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10021 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142535.pdf [firstpage_image] =>[orig_patent_app_number] => 10503120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911781 [patent_doc_number] => 20050175539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Compositions inhibiting rejection in organ transplantation and method of using the same' [patent_app_type] => utility [patent_app_number] => 10/496332 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6390 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175539.pdf [firstpage_image] =>[orig_patent_app_number] => 10496332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359749 [patent_doc_number] => 07485628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Inhibition of STAT-1' [patent_app_type] => utility [patent_app_number] => 10/491758 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11651 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485628.pdf [firstpage_image] =>[orig_patent_app_number] => 10491758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011387 [patent_doc_number] => 20050065103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Phosphorothioate antisense heparanase oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/483009 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5857 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065103.pdf [firstpage_image] =>[orig_patent_app_number] => 10483009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242865 [patent_doc_number] => 20070021360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase' [patent_app_type] => utility [patent_app_number] => 10/475684 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 49234 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021360.pdf [firstpage_image] =>[orig_patent_app_number] => 10475684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839176 [patent_doc_number] => 20030036516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CPG DINUCLEOTIDES' [patent_app_type] => new [patent_app_number] => 09/103745 [patent_app_country] => US [patent_app_date] => 1998-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4683 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036516.pdf [firstpage_image] =>[orig_patent_app_number] => 09103745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876663 [patent_doc_number] => 20010006816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'NOVEL PROPERTY EFFECTING AND/OR PROPERTY EXHIBITING COMPOSITIONS FOR THERAPEUTIC AND DIAGNOSTIC USES' [patent_app_type] => new-utility [patent_app_number] => 08/978637 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 39421 [patent_no_of_claims] => 244 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006816.pdf [firstpage_image] =>[orig_patent_app_number] => 08978637 [rel_patent_id] =>[rel_patent_doc_number] =>)